Media Coverage
Media Coverage
| Date | Media Coverage | Topic |
|---|---|---|
| Jul 13, 2011 |
''FDA calls for more congressional oversight on global drug economy'' "The Food and Drug Administration called on Congress Tuesday to make the laws that govern the global prescription drug economy stronger. In a report released Tuesday by the Pew Health Group, researchers looked at the globalization of pharmaceutical production and the domestic distribution of prescription drug, with an eye on how the FDA can more effectively regulate both." Source: The Daily Caller |
Drug Manufacturing and Distribution, Drug Safety |
| Jul 13, 2011 |
''Report Identifies Serious Gaps in Drug Safety Oversight'' "Americans' medicines are increasingly manufactured in developing countries, where oversight is lower than in the United States, according to a new white paper by the Pew Health Group." Source: Drug Discovery & Development Magazine |
Drug Manufacturing and Distribution, Drug Safety |
| Jul 13, 2011 |
''Pew track-trace call highlights congressional dallying'' "The FDA should have the power to mandate recalls, subpoena witnesses and documents, and destroy at the border any products that pose a public safety risk. So says Pew Health Group in a just published report, After Heparin: Protecting Consumers from the Risks of Substandard and Counterfeit Drugs." Source: FiercePharma Manufacturing |
Drug Manufacturing and Distribution, Drug Safety |
| Jul 14, 2011 |
''White paper lays out reform strategy for US medicines supply chain'' "US think tank Pew Health Group has called for a wide-ranging overhaul of the US pharmaceutical distribution system, including the introduction of a federal serialisation system, in order to protect consumers from unsafe medicines." Source: Securing Pharma |
Drug Manufacturing and Distribution, Drug Safety |
| Jul 16, 2011 |
''How Safe Are the Drugs in Your Medicine Cabinet?'' "Do you want your new prescription drugs to be made under last century's oversight? Like it or not, that's likely what you're getting -- or worse -- according to recent research from the Pew Health Group. Increasingly, Americans' medicines are made overseas in place where the oversight isn't up to U.S. standards, according to the white paper, After Heparin: Protecting Consumers from the Risks of Substandard and Counterfeit Drugs." Source: Daily Finance |
Drug Manufacturing and Distribution, Drug Safety |
| Jul 18, 2011 |
''Pharmaceuticals: Report recommends measures to mitigate risk in a global supply chain'' "Keeping the public safe in an age of global pharmaceutical sourcing requires improved safety testing standards, greater industry oversight of contract manufacturers and suppliers, and expanded enforcement authority for FDA backed by stronger penalties and clearer accountability, says a new report from the Pew Charitable Trusts." Source: Chemical & Engineering News |
Drug Safety |
| Jul 21, 2011 |
''PEW Recommends Steps to Secure the Supply Chain'' "The pharmaceutical industry and US regulatory bodies have not responded adequately to the increasing level of outsourced manufacturing in countries such as China and India, according to a new white paper by the PEW Health Group." Source: Pharmaceutical Technology |
Drug Manufacturing and Distribution, Drug Safety |
| Jul 22, 2011 |
''Consumers Hold High Hopes for New Bureau'' ''If you've ever thought someone was playing fast and lose with the rules on your credit cards, credit score or mortgage, but you had no idea where to go with your complaint, you now have a place to turn.'' Source: The Chicago Tribune |
|
| Jul 28, 2011 |
''Tight Times Boost Business Credit Cards'' ''More small companies—already struggling with weak sales and tight lending—are being forced to rely on business credit cards to provide working capital.'' Source: The Wall Street Journal |
|
| Jul 29, 2011 |
''New drug regulator asks Congress for more power'' "Drug companies should take more responsibility for the safety of ingredients sourced overseas, and Congress should make them if they do not, according to the new U.S. drug regulator for import safety." Source: Reuters |
Drug Manufacturing and Distribution, Drug Safety |
